Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.

Pubmed ID: 29605211

Pubmed Central ID: PMC5881905

Journal: Respiratory medicine

Publication Date: April 1, 2018

Affiliation: Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA.

Link: https://ac.els-cdn.com/S0954611118300556/1-s2.0-S0954611118300556-main.pdf?_tid=989fb251-35c9-4172-a5e8-293e13bb33ab&acdnat=1528816100_63d49df2b832814df853a75b6366b6e8&link_time=2024-05-19_19:36:03.335106

MeSH Terms: Humans, Male, Female, Aged, Aged, 80 and over, Cardiovascular Diseases, Risk Factors, United States, Hospitalization, Lung, Comorbidity, Pulmonary Disease, Chronic Obstructive, Spirometry, Death, Cardiomyopathy, Restrictive, Outcome Assessment, Health Care

Grants: P30 AG021342

Authors: McAvay GJ, Vaz Fragoso CA, Van Ness PH, Murphy TE

Cite As: Vaz Fragoso CA, Van Ness PH, Murphy TE, McAvay GJ. Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons. Respir Med 2018 Apr;137:40-47. Epub 2018 Feb 27.

Studies:

Abstract

BACKGROUND: In prior work involving older persons, the reported associations of spirometric impairments with cardiovascular outcomes may have been confounded by age-related changes in lung function. Hence, using more age-appropriate spirometric criteria from the Global Lung Function Initiative (GLI), we have evaluated the associations of spirometric impairments, specifically restrictive-pattern and airflow-obstruction, with cardiovascular death (CV-death) and hospitalization (CV-hospitalization). In these analyses, we also evaluated the competing outcome of noncardiovascular death (nonCV-death) and calculated measures of relative and absolute risk. METHODS: Our study sample was drawn from the Cardiovascular Health Study (CHS), including 4232 community-dwelling white persons aged ≥65 years. Multivariable regression models included the following baseline predictors: GLI-defined restrictive-pattern and airflow-obstruction, age, male gender, obesity, waist circumference, current smoker status, ≥10 pack-years of smoking, hypertension, dyslipidemia, diabetes, and cardiovascular and cerebrovascular disease. Outcomes included adjudicated CV-death, CV-hospitalization, and nonCV-death, ascertained over 10 years of follow-up. Measures of association included hazard ratios (HRs), rate ratios (RRs), and average attributable fraction (AAF), each with 95% confidence intervals. RESULTS: Restrictive-pattern and airflow-obstruction were associated with CV-death (adjusted HRs: 1.57 [1.18, 2.09] and 1.29 [1.04, 1.60]) and with nonCV-death (adjusted HRs: 2.10 [1.63, 2.69] and 1.79 [1.51, 2.12]), respectively. Airflow-obstruction, but not restrictive-pattern, was also associated with CV-hospitalization (adjusted RRs: 1.18 [1.02, 1.36] and 1.20 [0.96, 1.50], respectively). The adjusted AAFs of restrictive-pattern and airflow-obstruction were 1.68% (0.46, 3.06) and 2.35% (0.22, 4.72) for CV-death, and 3.44% (1.97, 5.08) and 7.77% (5.15, 10.60) for nonCV-death, respectively. CONCLUSION: Assessment of GLI-defined spirometric impairments contributes to broad geriatric risk stratifications for both cardiovascular and non-cardiovascular outcomes.